BioSpace News Archive

Drug Development

Otonomy Presents Data Highlighting Potential of OTO-413, an Otic Sustained-Exposure Formulation of BDNF, to Treat Hearing Loss

Society for Neuroscience Features OTO-413 Presentation as Neuroscience 2018 Hot Topic

November 16, 2018
·
6 min read
Medtronic Presents IN.PACT SFA Trial Five-Year Data and Total IN.PACT All-Subjects Analysis in VIVA Late Breaking Clinical Trials

New Data Continue to Reinforce IN.PACT Admiral DCB as a Durable, Frontline Option to Address Treatment Challenges in PAD

November 16, 2018
·
5 min read
Biotech Beach

Mesa Biotech to Demonstrate New Accula Molecular POC Testing Platform at Medica 2018

Company to Participate in USA Corporate Executive Office Program

November 16, 2018
·
2 min read
Business

Optimum Strategic Communications Appoints Leading Healthcare Investor Anne Marieke Ezendam

Renowned fund manager and buyside analyst joins investor relations and strategic communications specialists

November 16, 2018
·
4 min read
Business

Camel-IDS Grabs $42 Million in Funding to Support Treatment for Brain Lesions

In announcing the round, Camel-IDS said the finances will be used for a phase Ib/II trial of its lead program CAM-H2, a treatment option in HER2-positive cancers, while further developing preclinical programs and broadening the pipeline.

November 16, 2018
·
2 min read
·
Alex Keown
Policy

As Brexit Looms, Biopharma Industry Prepares for the Worst

The UK’s exit from the European Union, Brexit, will impact numerous industries in the UK and Europe, but the biopharma industry has its own unique challenges.

November 16, 2018
·
4 min read
·
Mark Terry
Business

BioSpace Movers and Shakers for Nov. 19

Companies bolstered their leadership with additions to boards of directors and c-suite offices.

November 16, 2018
·
4 min read
·
Alex Keown
Business

Secarna Pharmaceuticals and MetP Pharma enter into a co-development agreement for transnasally delivered antisense oligonucleotide-based CNS therapeutics

Secarna’s proprietary antisense oligonucleotide platform LNAplusTM to be combined with MetP Pharma’s nasal drug delivery technology to develop novel treatment options for neurodegenerative diseases

November 16, 2018
·
4 min read
Business

MorphoSys AG Announces Third Quarter 2018 Results

Advancing proprietary pipeline; solid progress in partnered programs

November 16, 2018
·
15 min read
Business

EUROPE AND USA: AGREEMENT ON DEFINITION AND DIAGNOSIS OF SPECIFIC FORM OF HIGH BLOOD PRESSURE

Physician from Karl Landsteiner University of Health Sciences plays a part in global consensus-building process

November 16, 2018
·
4 min read